-
Something wrong with this record ?
Characterization of [3H]-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of [3H]-forskolin binding
Stöhr J, Novotny J, Svoboda P.
Language English Country Canada
NLK
ProQuest Central
from 1998-01-01 to 2007-05-31
Medline Complete (EBSCOhost)
from 2001-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1998-01-01 to 2007-05-31
Health & Medicine (ProQuest)
from 1998-01-01 to 2007-05-31
- MeSH
- Adrenergic beta-Agonists pharmacology MeSH
- Baclofen pharmacology MeSH
- Cell Membrane metabolism drug effects MeSH
- Financing, Organized MeSH
- GABA Agonists pharmacology MeSH
- Guanylyl Imidodiphosphate pharmacology MeSH
- Magnesium pharmacology MeSH
- Isoproterenol pharmacology MeSH
- Colforsin metabolism MeSH
- Binding, Competitive radiation effects MeSH
- Rats MeSH
- Cerebral Cortex metabolism MeSH
- Rats, Wistar MeSH
- Receptors, Drug MeSH
- Aging metabolism MeSH
- Suramin pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
Little is know about forskolin binding in the rat brain during ontogenetic development. For this paper, we have characterized specific binding sites for [3H]-forskolin in cerebrocortical membranes from young (12-day-old) and adult (90-day-old) rats. High-affinity, as well as super-high-affinity, [3H]-forskolin binding sites were detected in samples from both age groups tested, and the binding parameters of these sites differed significantly. Whereas the number of high-affinity [3H]-forskolin binding sites was higher by about 50% in adult than in young rats, their affinity was markedly (about 4 times) lower. In the presence of AlF4-, the number high-affinity [3H]-forskolin binding sites in samples from young rats rose to the level determined in samples from adult animals, and the number of super-high-affinity sites considerably increased in both age groups. The different characteristics of [3H]-forskolin binding found in cerebrocortical membranes from young and adult rats may be closely related to markedly diminished adenyl cyclase activity in preparations from adult animals. Results of our experiments with suramin indicated that this drug may act as a competitive inhibitor of [3H]-forskolin binding.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520337
- 003
- CZ-PrNML
- 005
- 20111210131101.0
- 008
- 090331s2005 xxc e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Stöhr, Jiří $7 xx0142453
- 245 10
- $a Characterization of [3H]-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of [3H]-forskolin binding / $c Stöhr J, Novotny J, Svoboda P.
- 314 __
- $a Department of Biochemistry of Membrane Receptors, Institute of Physiology, Academy of Sciences, Videnska 1083, 142-20 Prague 4, Czech Republic
- 520 9_
- $a Little is know about forskolin binding in the rat brain during ontogenetic development. For this paper, we have characterized specific binding sites for [3H]-forskolin in cerebrocortical membranes from young (12-day-old) and adult (90-day-old) rats. High-affinity, as well as super-high-affinity, [3H]-forskolin binding sites were detected in samples from both age groups tested, and the binding parameters of these sites differed significantly. Whereas the number of high-affinity [3H]-forskolin binding sites was higher by about 50% in adult than in young rats, their affinity was markedly (about 4 times) lower. In the presence of AlF4-, the number high-affinity [3H]-forskolin binding sites in samples from young rats rose to the level determined in samples from adult animals, and the number of super-high-affinity sites considerably increased in both age groups. The different characteristics of [3H]-forskolin binding found in cerebrocortical membranes from young and adult rats may be closely related to markedly diminished adenyl cyclase activity in preparations from adult animals. Results of our experiments with suramin indicated that this drug may act as a competitive inhibitor of [3H]-forskolin binding.
- 650 _2
- $a agonisté adrenergních beta-receptorů $x farmakologie $7 D000318
- 650 _2
- $a stárnutí $x metabolismus $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a baklofen $x farmakologie $7 D001418
- 650 _2
- $a kompetitivní vazba $x účinky záření $7 D001667
- 650 _2
- $a buněčná membrána $x metabolismus $x účinky léků $7 D002462
- 650 _2
- $a mozková kůra $x metabolismus $7 D002540
- 650 _2
- $a kolforsin $x metabolismus $7 D005576
- 650 _2
- $a GABA agonisté $x farmakologie $7 D018755
- 650 _2
- $a guanylylimidodifosfát $x farmakologie $7 D006165
- 650 _2
- $a isoprenalin $x farmakologie $7 D007545
- 650 _2
- $a hořčík $x farmakologie $7 D008274
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory léků $7 D011955
- 650 _2
- $a suramin $x farmakologie $7 D013498
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Novotný, Jiří, $d 1959- $7 xx0071144
- 700 1_
- $a Svoboda, Petr, $d 1949- $7 jn20000710631
- 773 0_
- $w MED00001020 $t Canadian journal of physiology and pharmacology $g Roč. 83, č. 7 (2005), s. 573-581 $x 0008-4212
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20090716095816 $b ABA008
- 999 __
- $a ok $b bmc $g 638140 $s 490939
- BAS __
- $a 3
- BMC __
- $a 2005 $b 83 $c 7 $d 573-581 $i 0008-4212 $m Canadian journal of physiology and pharmacology $x MED00001020
- LZP __
- $a 2009-B2/ipme